Hnrnpr Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox protein
| name = Heterogeneous Nuclear Ribonucleoprotein R
| gene = HNRNPR
| uniprot = O43399
| molecular_weight = ~72 kDa
| location = Nucleus, Cytoplasm
| family = hnRNP family
| domains = 3 RRMs (RNA Recognition Motifs)
}}
HNRNPR (hnRNP R) is an RNA-binding protein containing three RNA recognition motifs (RRMs), also known as RBDs (RNA-binding domains). Each RRM consists of approximately 90 amino acids with the characteristic RNP1 and RNP2 consensus sequences. The protein has an N-terminal glycine-rich region and a C-terminal proline-rich domain.
HNRNPR Protein (Heterogeneous Nuclear Ribonucleoprotein R) is a 738-amino acid RNA-binding protein encoded by the HNRNPR gene located on chromosome 1p36.22. This protein belongs to the hnRNP family and contains multiple RNA recognition motifs (RRMs) that enable it to bind to RNA molecules with high specificity. HNRNPR is predominantly localized in the nucleus but can shuttle between the nucleus and cytoplasm.
The protein plays critical roles in post-transcriptional gene regulation, including alternative splicing, RNA stability, and mRNA export. In neurons, HNRNPR is involved in synaptic plasticity and neuronal development. Dysregulation of HNRNPR has been implicated in amyotrophic lateral sclerosis (ALS) and various cancers.
Currently no direct therapeutic agents targeting HNRNPR, but research is ongoing to develop small molecules that modulate hnRNP protein function for ALS treatment.
The study of Hnrnpr Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.